1. Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study. (3rd October 2019) Authors: Arnold, Lesley M.; Whitaker, Susan; Hsu, Ching; Jacobs, David; Merante, Domenico Journal: Current medical research and opinion Issue: Volume 35:Number 10(2019) Page Start: 1825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗